A recent change to Michigan's product liability law could have national implications. Experts at Sidley Austin detail the changes in Michigan, and explain what it could mean for pharmaceutical companies marketing products in Michigan and beyond.
- Start Fast, Finish Fast: How To Complete Projects On Time
- Small Startup Going For A Big Play In Obesity
- A View From The Co-Chair Of Israel’s Biopharma Industry Trade Organization
- Leveraging Fractional Expertise to Drive Project Success and Cost Savings
- Examining The Growth Of Biopharma In Developing Countries
- Why Fusion Pharma Is The Latest Billion Dollar Big Pharma Buy In Radiopharmaceuticals
- What The Emerging Science Tells Us About Treating Obesity
- Exploring Functional Uses Of AI In Life Sciences
COMPANIES TO WATCH
-
Companies To Watch: Antiva Biosciences
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
-
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
-
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
-
Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome.
WHERE ARE THEY NOW
-
Where Are They Now? Novo Nordisk
In a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
-
Where Are They Now? Ono Pharmaceuticals
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
-
Where Are They Now? Roivant
"Where Are They Now?" looks back, and forward, at companies and executives previously covered in Life Science Leader magazine.